Meribank Biotech Co., Ltd (4724.TWO)
TWD 28.55
(-1.89%)
TWD 28.55
(-1.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -29.69 Million | -41.32 Million | -22.99 Million | -17.73 Million | -3.74 Million |
| Net Income | -129.94 Million | -103.22 Million | -99.19 Million | -54.45 Million | -59.89 Million |
| Depreciation & Amortization | 36.53 Million | 32.16 Million | 29.46 Million | 23.76 Million | 20.76 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.17 Million | 21 Thousand | 340 Thousand | 1.13 Million | 1.74 Million |
| Change in working capital | 47.22 Million | 31.03 Million | 37.15 Million | 20.74 Million | -19.73 Million |
| Other non-cash items | -1.36 Million | -634 Thousand | 278 Thousand | -7.98 Million | 53.38 Million |
| Investing Cash Flow | 48.15 Million | -45 Million | -118.06 Million | 24.18 Million | 4.96 Million |
| Investments in PPE | -6.67 Million | -4.24 Million | -7.52 Million | -7.52 Million | -5.27 Million |
| Acquisitions | -4.41 Million | 6.72 Million | -10 Million | -1.5 Million | - |
| Investment purchases | -39.08 Million | -31.02 Million | -65.82 Million | 33.2 Million | - |
| Sales/Maturities of investments | 122.7 Million | - | - | 58.7 Million | 29.8 Million |
| Other Investing Activities | -24.37 Million | -16.46 Million | -34.72 Million | -15.49 Million | 10.24 Million |
| Financing Cash Flow | 295.84 Million | -20.65 Million | 281.81 Million | -10.21 Million | -7.29 Million |
| Debt repayment | -22.78 Million | -20.33 Million | -17.97 Million | -11.98 Million | -8.23 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 311.6 Million | - | 300 Million | 1.22 Million | - |
| Other Financing Activities | 7.02 Million | -316 Thousand | -202 Thousand | 548 Thousand | 947 Thousand |
| Accounts receivables | 17.59 Million | -6.24 Million | -14.19 Million | 1.52 Million | -12.56 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 1.53 Million | -4.84 Million | -667 Thousand | -285 Thousand | 122 Thousand |
| Other working capital | 12.58 Million | 29.31 Million | 18.66 Million | -36.23 Million | -7.29 Million |
| Cash at beginning of period | 85.15 Million | 192.15 Million | 51.39 Million | 55.16 Million | 61.22 Million |
| Cash at end of period | 399.45 Million | 85.15 Million | 192.15 Million | 51.39 Million | 55.16 Million |
| Capital Expenditure | -6.67 Million | -4.24 Million | -7.52 Million | -7.52 Million | -5.27 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 314.29 Million | -106.99 Million | 140.75 Million | -3.77 Million | -6.06 Million |
| Free Cash Flow | -36.37 Million | -45.57 Million | -30.51 Million | -25.26 Million | -9.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.46 Million | -23.46 Million | -32.77 Million | -129.94 Million | -32.77 Million | -29.89 Million |
| Depreciation & Amortization | 10.2 Million | 10.2 Million | 9.24 Million | 36.53 Million | 9.24 Million | 9.02 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 586.5 Thousand | 1.17 Million | 586.5 Thousand | - |
| Change in working capital | -11.55 Million | -11.55 Million | 7.29 Million | 47.22 Million | 7.29 Million | 8.56 Million |
| Other non-cash items | 5.53 Million | 5.53 Million | 6.67 Million | -1.36 Million | 6.67 Million | 6.43 Million |
| Investing Cash Flow | -225.23 Million | -225.23 Million | 24.29 Million | 48.15 Million | 24.29 Million | -222.5 Thousand |
| Investments in PPE | -115.81 Million | -115.81 Million | -504.49 Thousand | -6.67 Million | -504.49 Thousand | -2.39 Million |
| Acquisitions | - | - | -2.2 Million | -4.41 Million | -2.2 Million | - |
| Investment purchases | - | - | - | -39.08 Million | - | - |
| Sales/Maturities of investments | - | - | - | 122.7 Million | - | - |
| Other Investing Activities | -109.41 Million | -109.41 Million | 27.01 Million | -24.37 Million | 27.01 Million | 2.17 Million |
| Financing Cash Flow | 77.67 Million | 77.67 Million | 153.62 Million | 295.84 Million | 153.62 Million | -5.69 Million |
| Debt repayment | - | - | - | -22.78 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 311.6 Million | - | - |
| Other Financing Activities | 77.67 Million | 77.67 Million | 153.62 Million | 7.02 Million | 153.62 Million | -5.69 Million |
| Accounts receivables | 1.31 Million | 1.31 Million | 1.5 Million | 17.59 Million | 1.5 Million | 7.28 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -1.59 Million | -1.59 Million | 778.5 Thousand | 1.53 Million | 778.5 Thousand | -9000.00 |
| Other working capital | -11.28 Million | -11.28 Million | 5 Million | 12.58 Million | 5 Million | 1.28 Million |
| Cash at beginning of period | - | - | - | 85.15 Million | - | - |
| Cash at end of period | -166.84 Million | -166.84 Million | 168.94 Million | 399.45 Million | 168.94 Million | -11.79 Million |
| Capital Expenditure | -115.81 Million | -115.81 Million | -504.49 Thousand | -6.67 Million | -504.49 Thousand | -2.39 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -166.84 Million | -166.84 Million | 168.94 Million | 314.29 Million | 168.94 Million | -11.79 Million |
| Free Cash Flow | -135.09 Million | -135.09 Million | -9.47 Million | -36.37 Million | -9.47 Million | -8.27 Million |
TIAOF
SEDA-UN
6762
5392
BHLIF
MKFG